HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tract sizes in percutaneous nephrolithotomy: does miniaturization improve outcome?

AbstractPURPOSE OF REVIEW:
To provide a summary of surgical outcomes in percutaneous nephrolithotomy (PCNL) according to various techniques and tract sizes.
RECENT FINDINGS:
Recent literature in this field concluded that standard PCNL (sPCNL) remains the optimal treatment for stones between 1 and 2.5 cm and can be managed with tracts 14-20 F, whereas small stones less than 1.5 cm can be treated with tracts under 14 F. According to new datasets, smaller tracts can be equally effective in the treatment and might offer the possibility to reduce bleeding, length of hospital stay, postoperative pain as well as overall complication rates when compared with sPCNL. On the other hand, longer operative time as well as lower stone-free rates, which have been the main drawbacks of the miniaturized approach, have recently shown to be comparable with sPCNL.
SUMMARY:
At present, tract size is a highly debatable topic in percutaneous stone therapy. New systems for miniaturized PCNL have been developed to achieve comparable stone-free rates while reducing the incidence of common complications. The adoption of these techniques demands skilled surgeons and institutional investment for the acquisition of new equipment.
AuthorsAlexander Heinze, Ali S Gozen, Jens Rassweiler
JournalCurrent opinion in urology (Curr Opin Urol) Vol. 29 Issue 2 Pg. 118-123 (03 2019) ISSN: 1473-6586 [Electronic] United States
PMID30507619 (Publication Type: Journal Article, Review)
Topics
  • Humans
  • Kidney Calculi (therapy)
  • Length of Stay
  • Miniaturization
  • Nephrolithotomy, Percutaneous (methods)
  • Nephrostomy, Percutaneous (methods)
  • Operative Time
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: